secwatch.observer — SEC 8-K summary
======================================

Issuer:     Histogen Inc. (—)
CIK:        0001383701
Form:       8-K
Filed at:   2023-06-05T23:59:59+00:00
Accession:  0000950170-23-026352
Event type: other_material
Sentiment:  negative
Materiality: 0.65
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Histogen receives Nasdaq deficiency notice for minimum bid price non-compliance
-------------------------------------------------------------------------------

- Nasdaq letter on June 5, 2023 citing bid price below $1.00 for 30 consecutive business days.
- Compliance period of 180 days until December 4, 2023 to regain $1.00 minimum closing bid for 10 days.
- If not cured, may request additional 180 days if meets all other Nasdaq listing standards.
- Stock continues trading on Nasdaq Capital Market under symbol HSTO during cure period.
- No assurance of regaining compliance; delisting risk remains.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1383701/000095017023026352/0000950170-23-026352-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1383701/000095017023026352/hsto-20230605.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-026352

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer